Zydus Cadila gets DCGI nod for world's first drug to treat liver disease
Posted by
www.biotecnika.org
The Ahmedabad-based company said the approved product is the first
ever drug anywhere in the world for treatment of Non-Cirrhotic
Non-Alcoholic SteatoHepatitis (NASH) which is a progressive disease of
the liver. The condition starts with fat accumulation in the liver
known as non-alcoholic fatty liver disease and progress to cirrhosis
and liver failure.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-dcgi-nod-for-worlds-first-drug-to-treat-liver-disease/articleshow/74496447.cms
Subscribe to:
Post Comments (Atom)
Post a Comment